# Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

> **NCT02063880** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 183 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Immune Reconstitution Inflammatory Syndrome

## Interventions

- **OTHER:** Urgent ART
- **OTHER:** Early ART

## Key facts

- **NCT ID:** NCT02063880
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2018-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02063880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02063880, "Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02063880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*